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Abstract
We developed a unified model of the GRK-mediated b2 adrenergic receptor (b2AR) regulation that simultaneously accounts
for six different biochemical measurements of the system obtained over a wide range of agonist concentrations. Using a
single deterministic model we accounted for (1) GRK phosphorylation in response to various full and partial agonists; (2)
dephosphorylation of the GRK site on the b2AR; (3) b2AR internalization; (4) recycling of the b2AR post isoproterenol
treatment; (5) b2AR desensitization; and (6) b2AR resensitization. Simulations of our model show that plasma membrane
dephosphorylation and recycling of the phosphorylated receptor are necessary to adequately account for the measured
dephosphorylation kinetics. We further used the model to predict the consequences of (1) modifying rates such as GRK
phosphorylation of the receptor, arrestin binding and dissociation from the receptor, and receptor dephosphorylation that
should reflect effects of knockdowns and overexpressions of these components; and (2) varying concentration and
frequency of agonist stimulation ‘‘seen’’ by the b2AR to better mimic hormonal, neurophysiological and pharmacological
stimulations of the b2AR. Exploring the consequences of rapid pulsatile agonist stimulation, we found that although
resensitization was rapid, the b2AR system retained the memory of the previous stimuli and desensitized faster and much
more strongly in response to subsequent stimuli. The latent memory that we predict is due to slower membrane
dephosphorylation, which allows for progressive accumulation of phosphorylated receptor on the surface. This primes the
receptor for faster arrestin binding on subsequent agonist activation leading to a greater extent of desensitization. In
summary, the model is unique in accounting for the behavior of the b2AR system across multiple types of biochemical
measurements using a single set of experimentally constrained parameters. It also provides insight into how the signaling
machinery can retain memory of prior stimulation long after near complete resensitization has been achieved.
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Introduction
The b2 adrenergic receptor (b2AR) is intimately involved in
the control of smooth muscle relaxation in airways and the
vasculature, in stimulation of the heart, and numerous other
physiologically important actions. Agonist stimulation of the b2AR
causes activation of the Gs/cAMP/ protein kinase A (PKA)
pathway. Agonist triggers b2AR desensitization that involves two
pathways, G protein-dependent highly amplified PKA phosphor-
ylation, and G protein-independent G protein coupled receptor
kinase (GRK) phosphorylation that in turn triggers arrestin
binding, internalization, recycling and resensitization [1–4].
Additionally, there is an important role for PKA regulation of
adenylyl cyclase (AC) and phosphodiesterase activity in the
desensitization of the response to b2AR stimulation [5,6].
We recently examined the turnover profiles of cAMP in HEK
293 cells expressing only endogenous b2AR [6]. Our study of the
b2AR desensitization was based on characterization of membrane
localized cAMP in single cells with genetically encoded cyclic
nucleotide-gated (CNG) channels in the presence of GRK and/or
PDE inhibitors, and measurements of PDE activity. A model was
developed that adequately described cAMP turnover based on
GRK-mediated b2AR desensitization and PDE activation by
PKA. Violin et al. [5] measured b2AR stimulation of cAMP
profiles using a GFP-YFP-tagged EPAC sensor (ICUE2) following
manipulation of GRK activities with siRNA to reduce levels of
GRKs, and inhibitors to reduce PDE activity.
As an extension of these studies, we have sought to model the
GRK module of the b2AR desensitization and resensitization as it
relates to measurements of phosphorylation, dephosphorylation,
internalization, recycling, desensitization and resensitization
(Figure 1). In previous studies we showed that HEK 293 cells
overexpressing the b2AR was an excellent system for examining
the biochemical parameters associated with the desensitization
process. Importantly, the time course and extent of desensitization
of the b2AR in these cells overexpressing the b2AR is similar to
that of the endogenous receptor [7]. In the overexpression system,
PKA-mediated phosphorylation of the b2AR shows an EC50
that is approximately 1000 fold lower than the EC50 for high
occupancy-dependent GRK-mediated phosphorylation of the
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mediated desensitization of the b2AR into two different modules.
At high concentrations of agonist we have shown that the GRK
pathway accounts for almost all of the desensitization of the b2AR
[8]. Here we have used a wide range of experimentally determined
b2AR parameters (Table 1) to model and simulate the key steps in
the consensus GRK pathway in response to varied agonist
concentrations. The data simulated were obtained from over 90
distinct experiments performed in HEK 293 cells stably overex-
pressing the human b2AR. Accounting for all these disparate data
using a single model provided strong constraints on the model, and
ensured that its applicability was not restricted to only one class of
data of the b2AR’s response repertoire. The model provides a
much needed quantitative description of the GRK pathway to
b2AR desensitization and resensitization.
Results/Discussion
Model of the GRK-Mediated b2AR Regulation Pathway
The presentmodel of the GRK-mediated regulationof the b2AR
pathway derives from consensus models that have appeared over
the last decade [1–4] that includes activation, GRK phosphoryla-
tion, arrestin binding and dissociation, desensitization, internaliza-
tion, recycling and resensitization of the receptor (see Figure 1). The
experimental rate constants were derived from either new
experiments or in some cases from previous publications as
indicated (Table 1). The equations corresponding to these reactions
(E1–E10) are described in Materials and Methods.
Our model incorporates several key assumptions. First, since all
the parameters used for modeling of the GRK pathway were
obtained using either isoproterenol (ISO) or epinephrine, full
agonists for the b2AR, we assume a simple two state model for the
receptor activation, where Rs indicates the inactive receptor on the
surface of the plasma membrane and R
*Ls, the agonist-induced
active receptor. Agonist binding to the receptor occurs with rapid
on/off-rates. The off-rates for ISO have been estimated to be $4/
min [9] and for epinephrine .100/min [10]. Based upon the Kds
for epinephrine (450 nM) and ISO (283 nM), the on-rates were
estimated to be very fast.
In the second set of assumptions we set the off-rates for a full
agonist like epinephrine and ISO to be 4/min and chose an
arbitrarily fast on-rate of ligand binding. This is done for the
pragmatic purpose of running simulations without having to use
the rapid rates, and also at the same time preventing the forward
rates from being rate limiting for accessibility of the receptor for
GRK phosphorylation. While the nuances of agonist binding to
the b2AR and activation of Gs have been modeled in far greater
detail [11,12], for our purposes these specific interactions have
been ignored because they occur at much shorter timescales
compared to the 0.5 to 30 min events associated with GRK
mediated b2AR desensitization and subsequent resensitization.
We also assume that the off-rates for ligand from the receptor are
independent of its status of phosphorylation or arrestin binding.
The effects of these events on ligand off-rates have not been
determined. There is evidence that arrestin stabilizes a high
affinity state of ligand binding and therefore might reduce ligand
off-rates [13]. Faster off-rates (5f in Figure 1) cause a faster
resensitization following removal of agonist. Slower off-rates would
lead to slower resensitization.
Third, we assume that the GRK phosphorylated b2AR (Rgs,
Rg
*Ls) has reduced activity (0.7) compared to unphosphorylated
b2AR, consistent with previous findings [14–16]. We also assume
that any arrestin bound receptors in the plasma membrane are
completely uncoupled. Additionally, to enable modeling of
resensitization of b2AR stimulation of adenylyl cyclase following
agonist treatment, and removal of the stimulus by addition of
antagonist, we represented the antagonist like a competitive
inhibitor that competes with the agonist for binding to the receptor
leading to lower agonist binding rates [17]. Treating the
antagonist as such necessitated the introduction of additional
molecular species in the model, viz. agonist free GRK phosphor-
ylated receptor, either bound to (ArrRgs) or free of arrestin (Rgs).
These molecules are usually at negligible levels, but at the instance
of addition of an antagonist like propranolol or rapid washout of
agonist, there is a transient increase in levels of these species.
Finally, we ignore spontaneous activation of the b2AR, since in the
absence of ISO treatment, GRK phosphorylation of the receptor
is negligible [16,18–20].
Fourth, we assumed that an activated b2AR undergoes a single
event of GRK phosphorylation and that it can be dephosphorylated
Figure 1. Reaction diagram of the GRK-mediated b2AR
regulation. L is ligand; R
* is active state of b2AR; Rs and Ri are
surface/plasma membrane and internalized b2AR; Rg is GRK-phosphor-
ylated b2AR; Arr is arrestin. This reaction diagram describes the default
model for simulations using the rate constants as described in Table 1.
doi:10.1371/journal.pcbi.1000647.g001
Author Summary
The b2 adrenergic receptor (b2AR) is involved in regulating
many cellular processes such as smooth muscle relaxation
in the airways and the vasculature. Drugs that activate the
b2AR are used in treating asthma and chronic obstructive
pulmonary disorder (COPD), and prolonged use of these
drugs leads to the loss of their effects. Thus, a dynamic
model of how the b2AR responds to different drugs is
fundamental to their rational use. In this study a consensus
model of G protein coupled receptor kinase (GRK)-
mediated receptor regulation was formulated based on
quantitative measures of six processes involved in b2AR
regulation. This model was then used to simulate the
consequences of manipulating key rates associated with
the GRK-mediated b2AR regulation, leading to predictions
which will provide a useful framework for further tests and
elaborations of the model in basic and clinical research.
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of GRK phosphorylation to be dependent on [R
*] which is the
fraction of ligand-bound receptor. Thus in our model GRK
phosphorylation is dependent on receptor activation and agonist
concentration, which is consistent with agonist occupancy being the
rate determining step for GRK phosphorylation for strong agonists
[19,21–23]. We previously identified three sites responsible for
GRK phosphorylation of the b2AR, serines 355, 356, and 364 [8],
and our conclusions have been supported by mass spectrometry
[24]. All of our GRK phosphorylation studies are performed using
anantibodythatrecognizesphosphorylationofserines355,356,but
not of either alone. The experimentally measured GRK phosphor-
ylation rates upon treating with epinephrine range from 0.7–1.4/
min. We assume that since ISOis a full agonist, the phosphorylation
rates fall within the same range. Intermediate phosphorylated states
of other GPCRs like rhodopsin have been considered in kinetic
models of shorter timescales [25]. For the longer timescales that we
are modeling we ignore intermediary phosphorylated states and use
the binding of our phosphosite antibody as readout of GRK
phosphorylation of the receptor. The use of our anti-phosphosite
antibody for kinetic studies has been validated by numerous groups
[19,26–29]. With regard to the cellular locale of b2AR dephos-
phorylation, our group has shown in several studies that the plasma
membrane bound receptor, as well as that present in endosomes,
can undergo dephosphorylation [16,30].
Fifth, we assumed that the rate constants for arrestin binding to
the receptor following agonist-induced GRK phosphorylation was
27/min and dissociation from an agonist-free receptor was 11/
min [10] even though these were obtained from fluorescently
tagged proteins. We estimated the arrestin dissociation rate from
an agonist bound receptor complex (3b in Figure 1) to be ,4.0/
min given the stability of this complex from previous measure-
ments of the Kd [31]. Arrestin binding in turn leads to clathrin
coated pit internalization. Upon internalization of the b2AR we
assume that there is rapid ligand dissociation consistent with the
relatively high Kds and rapid on/off-rates of either ISO or
epinephrine [9,32]. We have shown that the rate of basal
internalization is negligible [33] and have set the rate at a level
that is 5% of the agonist-induced internalization.
Sixth, we assumed that the internalized b2AR can undergo; (i)
dephosphorylation following arrestin dissociation [34,35]; (ii)
recycling with or without dephosphorylation [16]; and (iii) a very
slow process of downregulation (t1/2=3–4 hours) [33,36,37].
Thus, in the present model that focuses on the rapid GRK-
mediated events (0–30 min), we do not further discuss potential
downregulation or de novo receptor synthesis as it contributes
little to the events being modeled in these time scales. Also, in
the model we allow any of the internalized receptors to be
downregulated at the same low rate. At present, it is not clear
what the precise mechanisms and pathways of downregulation of
the b2AR involve, although we have shown that it is a biphasic
process [37].
Finally, although GRK phosphorylation of the receptor and
arrestin binding to the receptor are second order reactions, we
represent them as pseudo-first order reactions. Our argument to
do so is that both GRKs and arrestins are in excess of even the
overexpressed receptor levels. Tran et al. [23] have shown that
GRK2, 5 and 6 levels exceeded overexpressed b2AR levels by
approximately 100 fold. Clark and Knoll [7] have shown that
the extent of desensitization is similar with HEK 293 cells
expressing endogenous (30 fmol/mg) versus overexpressed b2AR
(3000 fmol/mg). This suggests that arrestin is at levels sufficient to
give full desensitization even in a stable receptor overexpression
system. Further, Menard et al. [38] have shown that HEK 293
cells have the highest relative levels of GRK and arrestin when
compared to four other cell lines.
Table 1. Model parameters.
Reaction Name Parameter (/min) Reference/Rationale
Ligand (Agonist) On k1f=k 4b=k 5b=500 Rates used to achieve fast ligand binding so that it is not rate limiting.
a
Ligand (Agonist) Off k1b=k 4f=k 5f=4 Rates used to achieve fast ligand binding so that it is not rate limiting.
a
Ligand (Agonist) On – in the presence
of an antagonist
k1f=k 4b=k 5b=0.005 Antagonist is assumed to behave as a competitive inhibitor [17] so the
agonist binding rates are greatly reduced.
Ligand (Agonist) Off – in the presence
of an antagonist
k1b=k 4f=k 5f=4 Agonist off-rates are unaffected in the presence of an antagonist that
behaves like a competitive inhibitor.
GRK phosphorylation k2f=a[R*]1.4 Initial rate of GRK phosphorylation on treatment with 10 mM
epinephrine=0.7–1.4/min [19].
b
GRK dephosphorylation k2b=k 7f=k 10f=0.036 Phosphorylated receptor t1/2=18 min [16].
Arrestin On – to an agonist-bound receptor k3f=27.0 Rate of arrestin binding=26.665.9/min [10].
Arrestin Off – from an agonist-bound receptor k3b=4.0 Rate of arrestin dissociation assumed to match measured Kd.
Internalization k8f=0.22 k f=0.22/min [19].
Basal Internalization k11b=k 12f=k 13b=0.0085 Rates used to match negligible basal internalization [33].
Arrestin Off – from an agonist-free receptor k6f=k 9f=11.0 Rate of arrestin dissociation=10.861.2/min [10].
Receptor Degradation k14f=k 15f=k 16f=0.004 t1/2,3–4 hours [36].
Receptor Recycling k11f=k 13f=0.09 kf=0.09/min [19].
aOff-rates for ISO $4/min [9], epinephrine .100/min [10]. For a Kd of 450 nM (epinephrine) and 283 nM (ISO) the calculated on-rates are very fast. Slowing down the
forward-rates to 500/min does not affect the downstream events being simulated since they happen at a slower time scale. The ligand off-rate is not set at lower than
4/min in order to avoid making it rate limiting for arrestin dissociation.
ba=Coupling efficiency relative to epinephrine; ISO is assumed to have the same coupling efficiency as epinephrine since they are both full agonists. The relative
coupling efficiencies for partial agonists are as follows, Epinephrine=ISO=1, Fenoterol=0.66, Formoterol=0.63, Terbutaline=0.33, Zinterol=0.33, Albuterol=0.25,
Salmeterol=0.13, Dobutamine=0.04 and Ephedrine=0.03. [R
*]=([Rtotal] [Agonist]/([Agonist]+(Kd agonist)); [Rtotal]=1;K d epinephrine=450 nM; KdI S O=283 nM. Simulated
phosphorylation rate=a[R
*]1.4 (for epinephrine);=a[R
*]0.7 (for ISO).
doi:10.1371/journal.pcbi.1000647.t001
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Our mathematical model of GRK regulation of the b2AR was
validated by running simulations and comparing these to in vitro
experiments. The experiments include the six distinct biochemical
measurements of the agonist-regulated WT b2AR desensitization
and resensitization processes. These were derived from ,90
distinct experimental measurements obtained across a range of
ligand concentrations in HEK 293 cells expressing the WT b2AR
(Figures 2, 3). The results of the modeling of these experiments are
discussed below.
Phosphorylation. Figure 2A shows that the model captured
the overall kinetics of the time course for GRK phosphorylation of
the b2AR over a 1000 fold range of epinephrine stimulation from
0–30 min and in response to various partial agonists (Figure S1).
GRK phosphorylation of the WT b2AR was measured in whole
cell extracts with analysis of western blots using the phosphosite
specific antibody, anti-pS (355, 356), in HEK 293 cells [19]. GRK
phosphorylation of the b2AR was simulated by setting agonist
concentrations and time of treatment equal to the corresponding
experimental treatment. At the end of the simulation run, the sum
total of the six GRK phosphorylated species, whether cytosolic or
plasma membrane bound, was plotted against the experimentally
measured GRK phosphorylated b2AR.
Dephosphorylation. Simulation of the dephosphorylation
of the GRK phosphorylated b2AR is shown in Figure 2B.
Dephosphorylation was measured after treatment of cells with
either 1.0 mM or 10 nM ISO for 5 min followed by addition
of 1.0 mM propranolol and measurement of the loss of WT
b2AR phosphorylation using the anti-pS (355, 356) antibodies.
Just like the experiments, the simulations were performed in two
parts. The first part dealt with agonist treatment that allowed for
phosphorylation of the receptor, and the second part involved
treating with an antagonist which allowed for measuring/
simulating dephosphorylation. The rate of agonist binding was
calculated as described in Table 1, and the time and concentration
of agonist treatment were dependent on the experimental protocol
being simulated. At the end of the first run the concentrations of all
forms of b2AR were set as initial concentrations for the second
part. Antagonist binding was simulated as competitive inhibition.
The net effect was that in the presence of an antagonist, agonist
binding rates were reduced 100,000 fold, but the dissociation rates
remain unchanged. At the end of the simulations the sum total of
the six GRK phosphorylated species were plotted against the
experimentally measured GRK phosphorylated b2AR. The model
simulates well the dephosphorylation profile (Figure 2B) across a
100 fold agonist concentration range.
Internalization. Receptor internalization was measured
using [
3H]CGP-12177, following a 20 min treatment with ISO
as previously described [16]. The internalization of the b2AR was
simulated by setting agonist concentrations and the time of
Figure 2. Comparisons of four experimental results with simulations of the model. Panels A–D: Comparisons of simulations (continuous
lines) of the model shown in Figure 1, with experimental data obtained in HEK 293 cells stably overexpressing the FLAG WT b2AR (discrete data
points). (A) Time course of GRK phosphorylation of the receptor on treatment with different concentrations of epinephrine [19]. (B)
Dephosphorylation of the GRK phosphorylated site on the receptor after 5 min treatment with either 1.0 mM or 10 nM ISO (red bar) followed by
addition of propranolol (blue bar) and measure of loss of GRK site phosphorylation. Phosphorylated receptor is expressed as a percent of
phosphorylation achieved at the end of 5 min treatment with either agonist concentration [16]. (C) Recycling of the receptor after 20 min treatment
with 1mM ISO followed by rapid washout of agonist [33]. (D) Internalization of the b2AR on treatment with various concentrations ISO as indicated.
Surface receptor is measured by the loss of [
3H]CGP-12177.
doi:10.1371/journal.pcbi.1000647.g002
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simulation run the sum total of all the plasma membrane bound
b2AR was juxtaposed (Figure 2D) against the experimentally
measured surface b2AR. Model simulations of bAR inter-
nalization (Figure 2D) matched the experimental results across a
wide range of agonist concentrations.
Recycling. Receptor recycling was measured using [
3H]CGP-
12177 binding following treatment of cells with 1.0 mM of ISO and
washout of agonist as previously described [8]. Recycling was
simulated similar to dephosphorylation because both experiments
involved a period of agonist treatment followed by either a rapid
washout or antagonist treatment. At the end of simulating the
recycling protocol the sum total of all the plasma membrane bound
b2AR is juxtaposed (Figure 2C) against the experimentally
measured surface b2AR. Visual inspection shows an excellent fit.
Desensitization. Phosphorylation, dephosphorylation, inter-
nalization, recycling and arrestin recruitment rates were explicitly
modeled and the experimental measures of these rates defined the
rates used in the model for these individual steps. Experimental
measures of desensitization and resensitization were measures of
downstream events, namely activation of AC. Since AC was not
explicitly modeled, the receptor species capable of activating AC,
namely, Rs,R
*Ls,R g
*Ls and Rgs were matched against the
experimental measure of cAMP production, and in doing so we
validated our model to data sets not used to develop the model.
The b2AR desensitization experiments (Figure 3A) were
performed in HEK 293 cells stably overexpressing either WT
b2AR or a b2AR lacking the two PKA consensus sites (S261,
262A and S345, 346A termed PKA-). The rationale for using
the PKA- was to eliminate the contribution of PKA to the
desensitization as previously described [8]. While the PKA
component of desensitization is minimal at longer times of agonist
treatment at high concentrations, it does contribute a small
component of desensitization both at lower agonist concentrations
and for shorter treatment times. Desensitization of b2AR
stimulation of adenylyl cyclase was performed as previously
described [19,39]. The b2AR desensitization was simulated by
setting agonist concentrations and time of treatment as per the
experimental protocol being simulated. At the end of the
simulation run, the total of the three active forms of the b2AR
and naı ¨ve receptor was juxtaposed (Figure 3A) against the
experimentally measured active b2AR. As expected from the
contribution of the PKA desensitization, we found that our
GRK-mediated b2AR regulation model underestimated the
experimentally determined desensitization over the first two
minutes of agonist treatment for the WTb2AR, but there was
good agreement with longer treatment times. However, our model
matches well the desensitization measured in the PKA- cells that
overexpress the b2AR lacking the PKA consensus site, thus,
supporting our argument that the model misses the PKA
component that contributes to immediate early desensitization.
Resensitization. Figure 3B shows the results of simulation of
receptor resensitization. Resensitization of b2AR stimulation of
AC following agonist treatment (15 min, 1.0 mM ISO) and
addition of the low affinity antagonist, metoprolol for the times
indicated was measured as described in Materials and Methods.
The resensitization of the b2AR was simulated in two parts, as
described for dephosphorylation and recycling above. At the end
of the simulation run the sum total of all the active forms of
the b2AR is juxtaposed (Figure 3B) against the experimentally
measured active b2AR. We see that using the default model there
is a spike in the initial rate of resensitization relative to the
experimental values. The spike can be ablated if we assume a
ten-fold lower rate of ligand dissociation from an arrestin-bound
receptor complex based on the apparent stability of this complex
[31].
Sensitivity analysis of desensitization and resensi-
tization. The univariate sensitivity analyses were carried out
to test the effect of up to a twenty-fold increase or decrease in
individual rates on the simulation results of desensitization
and resensitization under conditions described in Figure 3
(Figures S2, S3).
Significant deviations from experimental desensitization mea-
surements were obtained for perturbations of only three rates.
Consistent with the model, decreasing GRK phosphorylation (k2f)
reduced the desensitization at earlier time points. Reducing
arrestin affinity for the receptor-ligand complex (k3f,k 3b) decreased
desensitization at later time points.
The resensitization sensitivity analysis (Figure S3) results are
complicated because we first desensitize the system for 15 min.
This affects the starting values of resensitization. Decreasing
internalization of ArrRg
*Ls (k8f) reduces the amount of receptor
Figure 3. Validation of the model with two sets of experimental results. Validation of the simulations (continuous lines) of the model shown
in Figure 1, with experimental data obtained in HEK 293 cells stably overexpressing the FLAG WT b2AR (discrete data points). (A) Desensitization of
b2AR stimulation of adenylyl cyclase after treatment with 10 mM ISO. Inset shows desensitization obtained on 30 nM ISO stimulation. Red – simulated
results; Black – WT cells; Blue - cells stably overexpressing b2AR lacking PKA phosphorylation sites (PKA-). At lower concentrations the model matches
PKA- desensitization more closely since it does not include PKA-mediated b2AR desensitization. (B) Resensitization of the b2AR stimulation of
adenylyl cyclase. WT b2AR were stimulated with 1mM ISO for 15 min, followed by addition of metoprolol as described in methods. Dotted line shows
simulated % activity of the b2AR when ligand dissociation from arrestin-bound receptor complex is reduced by ten-fold.
doi:10.1371/journal.pcbi.1000647.g003
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Thus at the start of resensitization simulation we begin at a higher
baseline and this overestimates the resensitization. As the
simulation progresses there is no significant effect of perturbing
internalization rates. Increasing recycling (k11f,k 13f) reduces the
amount of internalized receptor and therefore leads to an
overestimation of resensitization.
Model Predictions for Variations in Rates of GRK
Phosphorylation and Arrestin Binding
In various cell types GRKs and arrestins differ in overall
expression levels, localization [40,41], post-translational modifica-
tions [42–45] and have been frequently targeted for knockdown or
overexpression [28,44,46–48]. We were interested in seeing model
predictions when we varied the levels or activity of these two
b2AR regulatory proteins on phosphorylation, desensitization and
internalization over a 0–30 min time course. To simulate this we
varied GRK phosphorylation and arrestin binding rates ten-fold,
both above and below the default rates.
GRK rates. Decreasing the GRK phosphorylation rates
(Figure 4 A–C), at saturating concentrations of ISO, resulted in
decreased initial phosphorylation levels, whereas the steady state
rateswere unchanged (Figure4A).IncreasingGRK phosphorylation
rates did not have a marked effect on the initial phosphorylation and
maximum phosphorylation. This is an interesting observation
because GRK knockdown and overexpression studies are often
performedatsteadystateandatsaturatingagonistconcentrations.In
principle this increases the risk of false negative results. Our data and
simulationssuggestthatamorerigorousapproachismeasurementof
initial rates of b2AR phosphorylation at subsaturating agonist
concentrations. We show that the simulated effects of variations in
rates of GRK phosphorylation are more pronounced following
50 nM ISO treatment (Figure S4). With respect to internalization
(Figure 4B), lowering the GRK phosphorylation rates has marked
effects on the initial rates of internalization, with little effect on
the maximum amplitude. The effects on desensitization due to
variation in phosphorylation rates were similar to the effects on
phosphorylation, but phase shifted because these are sequential
events (Figure 4C). As with phosphorylation therefore, measure-
ments ideally should be made at the earlier time points and low
agonist concentrations to detect significant changes.
Arrestin rates. Similar to the analyses above, we varied
the rates of arrestin binding by ten-fold and studied the effect it
had on phosphorylation, desensitization and internalization
(Figure 4D–F). Neither increasing nor decreasing arrestin
binding rates had significant effects on the initial maximum
amplitude of phosphorylation (Figure 4D). Reduction in arrestin
binding rates (Figure 4E) reduced the extent of internalization
(,40% between 5–10 min), but increasing the rates did not
increase the maximum internalization any further. The most
drastic effect of varying arrestin binding rates was on the extent
of receptor desensitization (Figure 4F). Here again, like
internalization, a marked effect was visible only on reducing the
arrestin binding rates and not on increasing the rates.
Figure 4. Simulated effects of varying rates of GRK phosphorylation and arrestin binding. A–C: Simulated effects of ten-fold variation in
GRK phosphorylation rates on (A) phosphorylation, (B) internalization and (C) desensitization. D–E: Simulated effects of ten-fold variation in arrestin
binding rates on (D) phosphorylation, (E) internalization and (F) desensitization. Experimental data as given in Figure 2A, C, and Figure 3B.
doi:10.1371/journal.pcbi.1000647.g004
Modeling GRK Regulation of b2AR
PLoS Computational Biology | www.ploscompbiol.org 6 January 2010 | Volume 6 | Issue 1 | e1000647Phosphatase Access to the Membrane and
Phosphorylated Receptor Trafficking are Required to
Account for b2AR Response Characteristics
There has been some controversy about the possibility of plasma
membranedephosphorylationoftheGRKphosphorylatedreceptor
and the recycling of the phosphorylated receptor [30,34,49–51].
Recently we have shown that (i) b2AR can be dephosphorylated
when internalization is blocked with either hypertonic sucrose
treatment or through the use of a dominant negative form of
dynamin [30], and (ii) that dephosphorylation occurs with no
detectable internalization [16]. We have determined surface
dephosphorylation rates of ,0.04/min through two different
experimental methodologies (data not shown) as follows; (i)
dephosphorylation was measured after 30 s treatment with 1 mM
ISO at which point there shouldn’t be significant internalization; or
(ii) after pretreatment of cells with concanavalin A which reduced
internalization by ,80%.
Plasma membrane dephosphorylation has also been demon-
strated for other GPCRs such as the D1 dopamine receptor [52],
and for the TRH receptor [53]. To further investigate these
processes, we created six different models (Figure 5A–F) in which
the effect of plasma membrane and internalized b2AR dephos-
phorylation and recycling of phosphorylated receptor on total
dephosphorylation was explored in six possible combinations.
All six models were tested (Figure 5A–F) with various com-
binations of plasma membrane and cytosolic dephosphorylation
and recycling of phosphorylated receptor. To aid in our
interpretation of the cellular distribution of the phosphorylated
b2AR, we plotted the total (black), the surface (red) and cytosolic
(blue) phosphorylated b2AR. Of the six models tested only three
Figure 5. Simulated effects of phosphatase location and recycling of phosphorylated b2AR on receptor dephosphorylation. HEK 293
cells stably overexpressing WT b2AR were treated for 5 min with 1 mM ISO (red bar) followed by washout and addition of 1 mM propranolol (blue bar).
Experimental data [16] are shown as discrete points with standard errors and the simulations are shown as continuous lines. The black lines are the
total phosphorylated receptor, red indicates the phosphorylated receptor on the plasma membrane and blue indicate internalized levels of
phosphorylated b2AR. (A) Model A allows for dephosphorylation of both the internalized and plasma membrane bound receptor along with recycling
of phosphorylated and dephosphorylated receptor. (B) Model B disallows plasma membrane dephosphorylation but allows both dephosphorylation
of the internalized receptor and recycling of phosphorylated receptor. (C) Model C allows for dephosphorylation of both the internalized and plasma
membrane bound receptor but limits recycling to only dephosphorylated receptor. (D) Model D allows for dephosphorylation only at the plasma
membrane and also allows recycling of phosphorylated receptor. (E) Model E allows for dephosphorylation only at the plasma membrane and
disallows recycling of phosphorylated receptor. (F) Model F allows for dephosphorylation only after internalization and prevents recycling of
phosphorylated receptor.
doi:10.1371/journal.pcbi.1000647.g005
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dephosphorylation kinetics. Figure 5A shows results from model
A, the default model (Figure 1, Table 1) used throughout the paper
that matches other biochemical readouts presented (Figures 2, 3).
In Figure 5C, disallowing recycling of phosphorylated receptor
does not affect the simulated total rate of b2AR dephosphoryla-
tion. Even though this scenario is theoretically tractable, it does
not match experimentally observed phenomena. Tran et al. [16]
showed through immunolocalization of pS (355,356) on b2ARs
that the phosphorylated receptor can recycle back to the plasma
membrane after 3 min of recycling after a 5 min treatment with
1mM isoproterenol. Pippig et al. [34] have shown that treating
A431 cells with a phosphatase inhibitor did not affect the recycling
of b2ARs in these cells. This would mean that phosphorylated
receptor would have the same rate of recycling as the net rate of
recycling. In Figure S5A–E we test model C against other
biochemical readouts and show that in the absence of phosphor-
ylated receptor recycling, the model does not match well with
internalization (Figure S5B), recycling (Figure S5C) and resensi-
tization (Figure S5E).
Figure 5D explores a scenario that allows for dephosphorylation
only at the plasma membrane and allows for recycling of the
phosphorylated receptor. The measured dephosphorylation rates
match the simulated dephosphorylation quite well. Though
theoretically feasible, absence of cytosolic dephosphorylation is
at variance from experimental observations of the b2AR system
[16,34,35]. In Figure S5F–J we test this model for other
biochemical measurements and show that in the absence of
cytoplasmic dephosphorylation, plasma membrane dephosphory-
lation has to be 30 fold higher to match the phosphorylation data
(Figure S5F).
In Figure 5E we test a scenario that allows for dephosphory-
lation only at the plasma membrane and disallows recycling of
phosphorylated receptor. In this paradigm the total dephosphor-
ylation rates are markedly reduced. In Figure 5F, which models
the receptor system as per the current dogma [22,54], we show
that in the absence of both plasma membrane dephosphorylation
and recycling of phosphorylated receptor, the system fails to
achieve more than 50% dephosphorylation which is at odds with
our experimental data. The major consequence of this model is
that it essentially freezes the plasma membrane level of
phosphorylated b2AR. This phenomenon is exaggerated when
recycling of phosphorylated receptor is allowed as in Figure 5B.
Thus of the three models that capture dephosphorylation kinetics
of the receptor, only one model viz. model A (Figure 1, Table 1,
Figure 5A) can account for six different types of biochemical
readouts (Figures 2,3).
Frequency Coding in the b2AR Signaling System
In an earlier study of the resensitization of b2AR stimulation
following agonist treatment, we found that there was a rapid phase
of resensitization that we attributed to the rapid dissociation of
arrestin and a slower phase corresponding to recycling of receptor
(see Figure 3B) [16]. The rapid phase occurred with minimal
dephosphorylation, clearly dissociating it from resensitization. We
and others [10,19] speculated that the slow rate of dephosphor-
ylation would lead to a ‘‘memory of desensitization’’ upon a
washout phase followed by second treatment with agonist.
These, as well as most previous studies, were performed with
saturating levels of agonist for extended periods of time. In vivo this
type of exposure likely rarely occurs. Rather, the b2AR is exposed
to different amplitudes and frequencies of agonists in different
tissues; e.g., b2AR in the synapse is exposed to a higher
concentration of norepinephrine, but the delivery is pulsatile
[55,56] due to the rapid removal and reuptake of norepinephrine,
whereas following release of epinephrine from the adrenal gland,
much lower levels of agonist concentrations in the bloodstream are
achieved for relatively longer periods.
To explore the predictions of our model under various
frequencies of agonist stimulation, we first simulated a scenario
where there is a rapid burst of a high concentration of agonist for
30 s duration followed by 30 s washout. We assumed instanta-
neous agonist dissociation from the receptor (Figure 6A). We
observed that under this stimulation paradigm close to 80%
desensitization (green – active receptor) is achieved with almost
100% GRK phosphorylation (red – phosphorylated receptor) and
only about 20% internalization (black – surface receptor).
Following removal of agonist, resensitization is rapid due to rapid
arrestin dissociation. In spite of this near complete recovery,
we show that during this pulsatile activation of the receptor,
the receptor ‘‘remembers’’ prior exposure to an agonist and
desensitizes much more strongly on subsequent exposures. This is
because of the accumulation of the phosphorylated receptor due to
slower dephosphorylation.
In Figure 6B we stimulate with the same concentration of
agonist (1mM ISO) as used in the previous figure but instead of
rapid pulsatile delivery we model a continuous delivery for 5 min
followed by a wash for 5 min and subsequent restimulation for
5 min. Under this paradigm almost a 95% desensitization is
achieved but with more than 50% internalization. In Figure 6C we
test how the system would behave when challenged with sub-
saturating levels of agonist for longer periods of time. We
simulated a b2AR response to 50 nM ISO for 30 min followed
by 30 min wash and restimulation. Under longer periods of
agonist treatment (Figure 6B, C) the resensitization is biphasic (see
Figure 3B). The rapid phase of resensitization is dependent upon
arrestin dissociation while the slower phase is dependent upon
recycling and dephosphorylation [16].
The latent memory that we described in Figure 6A is only
observed at higher frequencies of agonist stimulation. For periods
of longer stimulation (Figure 6C), as might represent treatment
with a strong stable agonist in diseases such as asthma, receptor
recycling plays an important role in resensitization. Surprisingly, if
the longer term treatment is with a weak agonist like albuterol, a
very strong desensitization occurs since this agonist at saturation is
equivalent to the 50 nM treatment with ISO as previously
discussed [57]. The consequences of weak partial agonists are
shown in the supplementary Figure S1A, B.
Slow Dephosphorylation and Rapid Arrestin Dissociation
Account for a Latent Memory of b2AR Response to
Agonists
Having shown that the b2AR signaling system could ‘‘remem-
ber’’ prior stimuli (Figure 6A) we wanted to explore the inter-pulse
time (time between paired pulse stimulation) dependency and
effects of varied receptor dephosphorylation and arrestin dissoci-
ation on this latent memory. In Figure 7A we simulate a paired
pulse paradigm of receptor activation with 1mM ISO. As we
predicted, even though resensitization is rapid, the b2AR system
retained the memory of the previous paired pulse stimuli following
restimulation and desensitized more strongly in response to
subsequent stimuli as shown by the plot of ‘‘active’’ b2AR (green
lines). The simulations show that this latent memory is due to the
progressive accumulation of phosphorylated receptor on the
surface (red). This primes the receptor for faster arrestin binding
to surface receptor (blue) on subsequent agonist activation leading
to a greater extent of desensitization. Note that there is no
significant internalization following the pulsatile stimuli (black
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time reduces the memory (Figure 7B), as it allows significant
dephosphorylation to occur. The memory is robust and survives
beyond 30 min after the first stimulus. When the dephosphory-
lation rates are increased 2–50 fold over the default rate we see
that a 50 fold increase is required to ablate the memory of the
previous 6 s pulse of agonist (Figure 7C). Going in the other
direction, the result of decreasing the dephosphorylation rate 50
fold would result in a profound locking-in of latent memory
(simulation not shown).
Some GPCRs have an apparently much higher affinity for
arrestin such that arrestin does not dissociate rapidly following
internalization [58]. To investigate this possibility we increased the
affinity of arrestin for the receptor agonist complex in the model by
decreasing the dissociation rate of arrestin from the complex.
Increased residence of arrestin with the receptor complex increased
thetimerequiredforresensitization(Figure7D),whereasdecreasing
the residence time of arrestin on the receptor allowed for rapid
resensitization. We also increased the stability of ligand binding to
the receptor/arrestin complex by decreasing the off-rate 100 fold,
and still the property of memory was not lost (Figure S6), although
recovery time is extended. To summarize, the latent memory that
we predict in the b2AR system is due to the slow dephosphorylation
and rapid arrestin dissociation from the receptor.
Partial Agonism
Another application of the model is for predictions concerning
partial agonists. For most partial agonists the initial rate of ligand-
induced GRK site phosphorylation is proportional to coupling
efficiency (with the notable exception of cyclopentylbutanephrine)
[18,19,59]. In our simulations of partial agonist phosphorylation
(Figure S1A, B) we are able to predict the extent and time course
of phosphorylation solely by setting agonist occupancy propor-
tional to coupling efficiency where the coupling efficiency of
epinephrine, a full agonist, was set at 1.
Prolonged treatment with saturating concentrations of salme-
terol, a clinically important drug for asthma therapy, results in
decreased b2AR internalization relative to ISO, even though the
GRK phosphorylation of the b2AR is of comparable levels (Figure
S1A) [19,57,59]. Overexpression of arrestin restores some
internalization [57]. This has led us to propose that salmeterol
stabilizes an altered state of the receptor that has less affinity for
arrestin which leads to a decrease in b2AR internalization. We
modeled (Figure S1C) b2AR internalization on treatment with
salmeterol and found that a simulation based only on coupling
efficiencies overestimates grossly the extent of internalization. This
discrepancy can be corrected in part if we reduce by ten-fold the
rate of arrestin binding to a salmeterol-bound receptor complex.
However it takes a ten-fold decrease in the rate of arrestin binding
and a ten-fold increase in rate of arrestin dissociation from a
salmeterol-bound receptor complex to match the negligible
amount of experimentally measured internalization. This is
congruent with our idea that salmeterol-bound GRK-phosphor-
ylated b2AR complex (ArrRg
*Ls) has a lower affinity for arrestin.
Attempts at measuring salmeterol-induced desensitization have
been frustrated by the inability to wash salmeterol out. However
our previous work suggested much less desensitization relative to a
full agonist [57,59–61]. Now it is possible for us to simulate
salmeterol-induced desensitization using a model that matches
other experimental measurements like salmeterol-induced b2AR
phosphorylation and internalization. The result of the simulation
(Figure S1D) clearly supports the contention that salmeterol causes
a much reduced desensitization relative to ISO when both the on-
and off-rates of arrestin are changed ten-fold as in Figure S1C.
This may also help explain why salmeterol, a weak partial agonist,
is an effective treatment for asthma.
Model Limitations
Despite the ability of the model to capture the broad range of
data shown, a few limitations exist. The model in its current form
Figure 6. Simulations of the effects of frequency modulation. In these panels we describe the effect of varying the frequency of stimulation
on surface (black), phosphorylated (red) and active (green) receptor species. (A) Rapid stimulation with a train of 1 mM ISO pulses for 0.5 min followed
by a 0.5 min immediate washout. Note that this achieves more than 80% desensitization with only 20% internalization. (B) This panels shows the
results of a 5 min stimulation with 1.0 mM ISO and a 5 min washout. (C) Simulation of a prolonged 30 min stimulation with 50 nM ISO followed by
washout of 30 min. This panel shows that even with low b2AR occupancy (15%) the prolonged stimulation time gives substantial desensitization.
doi:10.1371/journal.pcbi.1000647.g006
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phosphorylation of the receptor. In the absence of the PKA
reactions the model cannot capture the behavior of the b2AR
signaling system at low agonist concentrations or PKA induced
PDE regulation. We previously showed that prestimulation of
PKA phosphorylation with forskolin does not alter the time course
of GRK phosphorylation [19], however, at high concentrations
of agonist the GRK phosphorylation appears to reduce PKA
site phosphorylation [20]. A further complication concerns the
possibility of AC regulation. Since we deal with only receptor-level
desensitization we have ignored these downstream regulatory
events.
We suggest a form of ‘‘cellular memory’’ occurs that allows the
system to remember prior stimuli which are difficult to measure
experimentally. For intact cell analysis this is confounded by the
rapid hydrolysis of cAMP caused by PKA stimulation of PDE and
the consequent difficulties in interpretation even with saturating
levels of PDE inhibitors. Resensitization experiments need to be
Figure 7. Basis for ‘‘Cellular Memory’’ in the b2AR signaling machinery. (A) Simulation of activation of b2AR by paired pulses of 1 mM ISO.
Higher desensitization is obtained for the second and third pulse. Colors indicate simulated receptor species as indicated in the figure. (B) Decay in
memory of prior stimuli on increase in inter-pulse period from 1–120 min. (C) Effect of up to 50 fold increase in surface dephosphorylation rates on
memory of prior stimuli. Default dephosphorylation rate is 0.036/min. (D) Effect of arrestin-b2AR complex stability on desensitization time courses
simulated by varying arrestin dissociation rates from the ligand-free complex on the surface. Default arrestin surface dissociation rate from the ligand-
free complex is 10/min.
doi:10.1371/journal.pcbi.1000647.g007
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recycling to show that under certain patterns of stimuli the system
can show a greater desensitization to the second stimuli as
suggested by the simulations. We also need to show that this effect
is abrogated by addition or upregulation of phosphatase activity.
Our simulations indicate that this potential upregulation must be
extreme (Figure 7C) to significantly change the retention of
memory. In that regard we recently reported on mutations of 3
lysines that greatly reduce ubiquitylation, and surprisingly cause
an ,5–7 fold increase in the rate of dephosphorylation of the
b2AR [36]. Consistent with our model this increase did not
appreciably alter either desensitization or internalization of the
receptor.
We show that the currently held dogma that disallows the
possibility of plasma membrane dephosphorylation of the receptor
and recycling of the phosphorylated receptor is clearly incompat-
ible with our modeling and previous experimental results. One
caveat though is that the effect of ligand-independent internali-
zation of the b2AR on dephosphorylation kinetics has not been
explored in detail. Ligand-independent internalization has been
shown to occur in other GPCRs like the cannabinoid CB1
receptor [62] and melanocortin MC4 receptor [63]. We have
previously shown in our cell lines that in the absence of agonist
there is no measureable internalization of the b2AR [33]. Recently
[64] it was shown that in HeLa cells transiently transfected with
b2AR or M3R there was measureable amounts of ligand-
independent internalization. It remains to be further examined if
this was an artifact of transient transfections or if constitutive
internalization of b2AR does occur in other cell lines and has an
effect on dephosphorylation kinetics. Preliminary simulations (data
not shown) on the effect of ligand-independent internalization on
dephosphorylation kinetics in model F (from Figure 5) show that
an increased rate of constitutive internalization will not rescue the
poor behavior of model F.
Concluding Remarks
Our long-term goal is to develop comprehensive, quantitative
models of b2AR-mediated signaling pathways. Such quantitative
models serve as a summary of the current state of understanding in
the field, and have many important applications: (i) understanding
of the mechanisms underlying the differences between b2AR
response in different tissue types; (ii) simulation of clinically
observed tachyphylaxis in b2AR associated with prolonged use of
b2AR agonists in asthma and COPD treatment; (iii) hypothesis
testing and generation of experimental predictions. The present
model represents a significant advance toward this goal, since it is
able to account for many salient b2AR response features in various
experimental studies performed in different cell lines.
Materials and Methods
Experimental Methods
For the majority of the new experiments performed for this
work, we used HEK 293 cells stably overexpressing the WT b2AR
tagged with an N-terminal FLAG epitope [16]. For select
experiments we used a WT b2AR tagged with HA on the N-
terminus [33], or WT b2AR tagged with both an HA (N-terminus)
and His6 (C-terminus) – Hb2ARH [39,59]. All of the stable HEK
293 lines were used with b2AR levels of from 3–6 pmoles/mg
membrane protein. We have found that these different tags do not
significantly alter any of the desensitization parameters discussed
in Table 1 [16,20,30,33,39,59], therefore for the present discussion
we refer to these stably expressing cell lines as expressing WT
b2AR. Also in some previously published experiments we used
epinephrine instead of ISO, and again we have found no
differences in the effect these strong agonists have on the
desensitization parameters at similar levels of receptor occupancy
[19].
b2AR internalization. WT bAR were treated with ISO for
varied periods of time. Following agonist treatment and extensive
washing, b2AR internalization was measured on intact cells using
the binding of [
3H]CGP-12177 (20 nM) as previously described
[16]. [
3H]CGP-12177 is a hydrophilic antagonist that labels only
surface (plasma membrane) receptor at 0–4uC. The binding assay
is conducted 61mM alprenolol, a b2AR antagonist that is used to
determine non-specific binding of [
3H]CGP-12177. The measure
of surface receptor at time 0 is assumed as 100% surface receptor.
b2AR recycling. WT b2AR were treated with agonist (ISO)
for 20 min to generate maximal internalization. Following agonist
treatment the cells were washed extensively to remove agonist,
incubated for the times indicated at 37uC to allow recycling.
Recycled b2AR levels were determined with [
3H]CGP-12177 [8].
The measure of surface receptor at time 0 is assumed as 100%
surface receptor.
b2AR desensitization and resensitization. Desensitization
of b2AR stimulation of adenylyl cyclase was measured as
previously described [8,16]. Briefly either the WT b2AR, or for
the experiment shown in Figure 2B, cells stably expressing the
b2AR with the two PKA consensus sites substituted with alanines
[8] were incubated with agonist (ISO) at various concentrations
and after washout of agonist, membranes were prepared on
sucrose step gradients. The extent of desensitization was measured
by determination of the increase in EC50 for ISO stimulation of
adenylyl cyclase relative to controls and the results expressed as
fraction activity remaining as discussed [16]. There is also a 35%
decrease in Vmax that our previous studies have shown is from
downstream effects, most likely on AC [8,65]. So in our current
model of receptor-level desensitization we ignore these Vmax
changes.
For resensitization of WT b2AR cells, propranolol cannot be
used for the blockade of agonist stimulation, since its rate of
dissociation is too slow to allow for a time course measurement of
resensitization. To circumvent this problem we used 100 mM
metoprolol [16], a low affinity (240 nM Kd) antagonist of the
bARs. After the various times allowing resensitization, cells were
washed free of metoprolol, and membranes were prepared and
assayed for ISO stimulation of adenylyl cyclase as previously
detailed [16]. The measure of AC activity in membranes at time 0
is assumed as 100% activity in desensitization and resensitization
experiments.
b2AR phosphorylation and dephosphorylation. GRK
phosphorylation of the b2AR was determined using anti-
phosphosite-specific antibodies to residues S(355, 356) as
described previously [19]. Briefly, WT b2AR were incubated
with ISO for varying times after which the whole cell b2AR was
extracted with solubilization buffer. The extract was incubated
with PNGase to remove glycosyl residues, treated with SDS
sample buffer and run on PAGE. After transfer the levels of
GRK site phosphorylation were determined by western blots.
Phosphorylation data was first normalized to receptor levels and
then for comparison between experiments to the maximum
epinephrine-stimulated value. For dephosphorylation WT b2AR
were treated for 5 min with either 1.0 mM or 10 nM ISO, after
which the cells were washed and incubated with medium
containing 0.1 mM propranolol to block further ISO stimulation
for the times indicated [16]. The loss of GRK site phosphorylation
was then measured by western blots as discussed above. In
dephosphorylation experiments the measure of phosphorylation
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concentrations.
Computational Methods
Simulation methodology and analysis tools. Since no
single experiment gives the full range of data needed to adequately
constrain the model we used an amalgamation of over 90 different
data points from distinct experiments from three different cell
types. The data sets chosen for modeling spanned measurements
across every possible step in the signaling pathway. The key
features we sought to match were general behavior of the signaling
components across cell types, if possible, under a given stimulus
paradigm. Most of the parameters for the model listed in the
Appendix and in Table 1 were based on biochemical values from
our experiments (when available). More details on the choices of
parameters are given in Table 1.
The reactions describing the total GRK-mediated regulation of
b2AR was written out using the Law of Mass-Action considering
the system to exist in equilibrium. The model was implemented
using Matlab R2008 (The Mathworks, Natick, MA) and a Runge-
Kutta solver. The code is available upon request. All analyses were
done using Microsoft Office Excel 2003 and plots were generated
using GraphPad Prism 4.
Simulation of perturbations of the rate constants for the
various parameters. The activities or amount of individual
signaling components of the pathway can vary in different
cell lines or by experimental manipulations such as over-
expression or knockdowns of GRKs, arrestins or phosphatases.
Simulations to account for these experimental variations were
performed by simply varying 2 to 50 fold the appropriate rate
constants.
Simulation of partial agonists. The simulations for partial
agonist-mediated activation of the b2AR were done by setting coupling
efficiencies of each agonist relative to epinephrine (a). The coupling
efficiencies/efficacies of different agonists were obtained from pre-
vious measurements [19]. The phosphorylation and internalization
measurements were made at saturating concentrations for different
agonists [19,57]. Since the coupling efficiencies were set relative to
epinephrine, agonist concentrations were set to saturating epinephrine
concentrations (10 mM) for the simulation run.
Sensitivity analysis of desensitization and resen-
sitization. The univariate sensitivity analysis for the model
was carried out to test the effect of variation of individual rates on
the simulation results of desensitization and resensitization. Except
for ligand binding and unbinding rates all other rates were
individually varied 2X, 5X, 10X, 20X above and below the
measured or default rates (Table 1). The results were then plotted
as the change from the average experimental measure of
desensitization or resensitization at different instances of time.
Ordinary differential equations for the GRK-mediated
b2AR regulation model
d½Rs dt~{(k1fzk11b)(Rs)z(k1b)(R Ls)z(k11f)(Ri) ð1Þ
d½R Ls dt~{(k1bzk2f)(R Ls)z(k1f)(Rs)z(k2b)(Rg
 Ls) ð2Þ
d½Rg
 Ls dt~{(k2bzk3fzk4f)(Rg
 Ls)z(k2f)(R Ls)
z(k3b)(ArrRg
 Ls)z(k4b)(Rgs)
ð3Þ
d½ArrRg
 Ls dt~{(k3bzk5fzk8f)(ArrRg
 Ls)
z(k3f)(Rg
 Ls)z(k5b)(ArrRgs)
ð4Þ
d½ArrRgs dt~{(k5bzk6fzk12f)(ArrRgs)z(k5f)(ArrRg
 Ls)ð5Þ
d½Rgs dt~{(k4bzk7fzk13b)(Rgs)z(k4f)(Rg
 Ls)
z(k13f)(Rgi)z(k6f)(ArrRgs)
ð6Þ
d½ArrRgi dt~{(k9fzk14f)(ArrRgi)z(k8f)(ArrRg
 Ls)z(k12f)(ArrRgs) ð7Þ
d½Rgi dt~{(k10fzk13fzk15f)(Rgi)z(k9f)(ArrRgi)z(k13b)(Rgs)ð8Þ
d½Ri dt~{(k11fzk16f)(Ri)z(k11b)(Rs)z(k10f)(Rgi) ð9Þ
d½Rdegraded dt~(k14f)(ArrRgi)z(k15f)(Rgi)z(k16f)(Ri) ð10Þ
Here kxf and kxb are the forward and backward rates for the
reaction number denoted by x. Rs=b2AR on the plasma
membrane; R
*Ls=Agonist bound b2AR on the plasma membrane;
Rg
*Ls=GRK phosphorylated b2AR that is on the plasma
membrane and is bound to an agonist; ArrRg
*Ls=GRK phos-
phorylated b2AR that is on the plasma membrane and is bound to
an agonist and arrestin; ArrRgs=GRK phosphorylated b2AR that
is on the plasmamembraneand is bound to arrestin;ArrRgi=GRK
phosphorylated b2AR that is in the internalized compartments and
is bound to arrestin; Rgi=GRK phosphorylated b2AR that is in the
internalized compartments; Ri=b2AR that is in the internalized
compartments; Rdegraded=Degraded b2AR in the cytoplasm.
The rates for models A–F shown in Figure 5 are set as follows.
Model A: All rates are set as described in Table 1, for the default
model.
Model B: k2b=k 7f=0/min since this model disallows dephos-
phorylation at the plasma membrane.
Model C: k13f=0/min since this model disallows recycling of
phosphorylated receptor.
Model D: k10f=0/min since this model disallows dephosphor-
ylation of the internalized receptor.
Model E: k10f=k 13f=0/min since this model does not allow
neither dephosphorylation of the internalized receptor nor
recycling of phosphorylated receptor.
Model F: k2b=k 7f=k 13f=0/min since this model as per the
currently accepted paradigm does not allow either dephosphor-
ylation of the receptor at the plasma membrane or recycling of
phosphorylated receptor.
Supporting Information
Figure S1 Comparison of simulated time course of GRK site
phosphorylation with experimentally measured phosphorylation in
response to various agonists. (A) The simulated time course of
GRK site phosphorylation of the b2AR in response to various
agonists is compared with experimentally measured phosphoryla-
tion [19]. Phosphorylation simulations for salmeterol (a=0.13;
blue line) were done with arrestin on-rate=0.1 k3f and arrestin
dissociation=10 k3b to complement with S1C-D. These results
(7)
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binding/unbinding (not shown). (B) Comparison of simulated and
experimentally measured receptor phosphorylation at 2 min of
agonist treatment normalized to phosphorylation achieved with
10 mM epinephrine [19]. (C) Comparison of simulated and
experimentally measured receptor internalization [57] post agonist
treatment. Simulated internalization for salmeterol (a=0.13; blue
lines) matches only when arrestin on-rate is 0.1 k3f and arrestin
dissociation is 10 k3b. This reduces the stability of the ArrRg
*Ls
complex a hundredfold. (D) Simulation of agonist induced
receptor-desensitization.
Found at: doi:10.1371/journal.pcbi.1000647.s001 (2.81 MB EPS)
Figure S2 Univariate sensitivity analyses of the model for
desensitization. (A–Q) Desensitization of b2AR stimulation of
adenylyl cyclase after treatment with 10 mM ISO simulated on
twenty-fold variation of individual rates. Negative values indicate a
simulated measurement higher than experimental measure.
Found at: doi:10.1371/journal.pcbi.1000647.s002 (1.21 MB EPS)
Figure S3 Univariate sensitivity analyses of the model for
resensitization. (A–Q) Resensitization of the b2AR stimulation of
adenylyl cyclase post 15 min stimulation with 1mM ISO is
simulated on twenty-fold variation of individual rates. Negative
values indicate a simulated measurement higher than experimen-
tal measure.
Found at: doi:10.1371/journal.pcbi.1000647.s003 (1.11 MB EPS)
Figure S4 Simulated effects of varying rates of GRK phosphor-
ylation. Effect of variations in GRK levels or activity on
phosphorylation at subsaturating concentration of ISO (50 nM)
is simulated by ten-fold up or down variations in GRK
phosphorylation rates.
Found at: doi:10.1371/journal.pcbi.1000647.s004 (1.13 MB EPS)
Figure S5 Comparisons of five experimental results with
simulations of model C and D. Through panels A–E we test
alternate models C and D to see how well they match other
experimental readouts of the b2AR signaling system besides
dephosphorylation (c.f. Figure 4C, D). Comparisons of simulations
(continuous lines) of model C (A–E) and model D (F–J), with
experimental data obtained in HEK 293 cells stably expressing the
WT b2AR (discrete data points). (A, F) Time course of GRK
phosphorylation of the receptor on treatment with 50 nM ISO
[19]. (B, G) Internalization of the b2AR on treatment with 1 mM
ISO. Surface receptor is measured by the loss of [
3H]CGP-12177.
(C, H) Recycling of the receptor after 20 min treatment with 1mM
ISO followed by rapid washout of agonist [33]. (D, I)
Desensitization of b2AR stimulation of adenylyl cyclase after
treatment with 10 mM ISO. (E, J) Resensitization of the b2AR
stimulation of adenylyl cyclase. WT b2AR were stimulated with
1mM ISO for 15 min, followed by addition of metoprolol as
described in Materials and Methods.
Found at: doi:10.1371/journal.pcbi.1000647.s005 (1.91 MB EPS)
Figure S6 Sensitivity of simulated ‘‘Cellular Memory’’ to the
stability of arrestin-receptor/ligand complex. Simulation of
activation of b2AR by paired pulses of 1 mM ISO. Higher
desensitization is obtained for the second and third pulse even on
100 fold increased stability of the arrestin-receptor/ligand
complex.
Found at: doi:10.1371/journal.pcbi.1000647.s006 (3.57 MB EPS)
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